Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.
Apricus Biosciences plans to initiate a Phase 2b study evaluating RayVa (alprostadil), the company’s investigative treatment for Raynaud’s phenomenon. In a press release, the company also announced it is exploring Orphan Drug ... Read more
The U.S. Food and Drug Administration (FDA) has granted Cytori Therapeutics Small Business status designation for fiscal year 2017, meaning that the company will pay reduced fees for regulatory filings that ... Read more